Log Type Authored on Log Message Log Node Authored by
Newsletter clicked Tue, 11/08/2022 - 13:18 Clicked https://za.progress.im/en Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened É Amanhã! Convite Lundbeck Webinar Internacional Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Convite Lundbeck Webinar Internacional Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter clicked Tue, 11/08/2022 - 13:18 Clicked https://brazil.progress.im/pt-br/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados Convite Lundbeck Webinar Internacional Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind Ireland newsletter Anonymous
OWA Status Wed, 10/12/2022 - 13:23 israel@progress.im manually updating trust level from 1 to 5 Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
OWA Status Wed, 10/12/2022 - 13:23 Updating trust level from 1 to 0 Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
OWA Status Wed, 10/12/2022 - 13:23 Updating trust level from 1 to 0 Anonymous
Profile edited Wed, 10/12/2022 - 13:23 Profile edited Anonymous
OWA Status Wed, 10/12/2022 - 13:23 slovenia@progress.im manually updating trust level from 1 to 5 Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - PROGRESS IN MIND SLOVENIJA E-NOVICE Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
OWA Status Wed, 10/12/2022 - 13:23 Updating trust level from 1 to 2 Anonymous
Log Type Authored on Log Message Log Node Authored by
Newsletter clicked Tue, 11/08/2022 - 13:18 Clicked https://za.progress.im/en Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened É Amanhã! Convite Lundbeck Webinar Internacional Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Convite Lundbeck Webinar Internacional Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter clicked Tue, 11/08/2022 - 13:18 Clicked https://brazil.progress.im/pt-br/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados Convite Lundbeck Webinar Internacional Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind Ireland newsletter Anonymous
OWA Status Wed, 10/12/2022 - 13:23 israel@progress.im manually updating trust level from 1 to 5 Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
OWA Status Wed, 10/12/2022 - 13:23 Updating trust level from 1 to 0 Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
OWA Status Wed, 10/12/2022 - 13:23 Updating trust level from 1 to 0 Anonymous
Profile edited Wed, 10/12/2022 - 13:23 Profile edited Anonymous
OWA Status Wed, 10/12/2022 - 13:23 slovenia@progress.im manually updating trust level from 1 to 5 Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - PROGRESS IN MIND SLOVENIJA E-NOVICE Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
OWA Status Wed, 10/12/2022 - 13:23 Updating trust level from 1 to 2 Anonymous